Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

Turk J Haematol. 2019 Aug 2;36(3):218-219. doi: 10.4274/tjh.galenos.2019.2019.0113. Epub 2019 May 9.
No abstract available

Keywords: Leukemia; Myelomonocytic; Chronic; Tumor lysis syndrome; Hematologic neoplasms.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Carcinoma, Hepatocellular / complications*
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / pathology
  • Chemoembolization, Therapeutic / adverse effects
  • Ethiodized Oil / adverse effects
  • Humans
  • Leukemia, Myelomonocytic, Chronic / complications*
  • Leukemia, Myelomonocytic, Chronic / drug therapy
  • Leukemia, Myelomonocytic, Chronic / pathology
  • Liver Neoplasms / complications*
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology
  • Male
  • Middle Aged
  • Tumor Lysis Syndrome / etiology*
  • Tumor Lysis Syndrome / pathology

Substances

  • Antineoplastic Agents
  • Ethiodized Oil